Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Ano de publicação
Tipo de documento
Assunto da revista
Intervalo de ano de publicação
1.
Arzneimittelforschung ; 33(5): 792-5, 1983.
Artigo em Alemão | MEDLINE | ID: mdl-6347211

RESUMO

Distorsions of the upper ankle joint in 27 sport students were treated with an ointment dressing once daily in a double-blind test over 8 days. 14 cases were treated with Hepathrombin-50,000-Salbe Adenylchemie (100 g contain 50,000 I.E. heparin, 300 mg allantoin and 400 mg dexpanthenol) and 13 cases with the ointment base. The therapeutic effect was objectified based on measurements taken after 1, 2, 4, and 8 days of the foot volume (weight of displaced water by overflow at 23 cm height) and mobility of the joint. Moreover, resting, movement and pressure pain were individually assessed and compiled as a pain score (0-12). In the Hepathrombin group, swelling subsided continuously from 100 to 42% and the pain score decreased from 12 to 3. With application of the ointment base, swelling increased at first to 114% after 2 days, then decreased until Day 8 to 86% of the initial value. The pain score decreased from 12 to 7. The superiority of Hepathrombin-Salbe over the ointment base could be statistically demonstrated; the difference between the two groups was significant with respect to swelling after just one day, and with respect to joint mobility after just 2 days of treatment.


Assuntos
Alantoína/uso terapêutico , Traumatismos do Tornozelo , Heparina/uso terapêutico , Ácido Pantotênico/análogos & derivados , Administração Tópica , Adulto , Traumatismos em Atletas/tratamento farmacológico , Ensaios Clínicos como Assunto , Método Duplo-Cego , Combinação de Medicamentos/uso terapêutico , Feminino , Humanos , Masculino , Pomadas , Dor/tratamento farmacológico , Ácido Pantotênico/uso terapêutico , Fatores de Tempo
2.
Arzneimittelforschung ; 27(6B): 1355-7, 1977.
Artigo em Alemão | MEDLINE | ID: mdl-579125

RESUMO

Experience with 2-(2-hydroxyethoxy)-ethyl-N-(a,a,a-trifluoro-m-tolyl)-anthranilate (etofenamate; active principle of Rheumon Gel) in the treatment of traumatic injury to the ankle joint is reported. In testing the effect of the product, volumetric measurements were carried out using an apparatus that permits highly accurate assessment by a simple and rapid method of measurement. The studies were carried out as a double blind trial. The result of the study shows that compared with placebo gel the increase in volume due to haematoma is reduced statistically significantly more rapidly under treatment with etofenamate. No localized or generalized side effects were observed.


Assuntos
Traumatismos em Atletas/tratamento farmacológico , Ácido Flufenâmico/análogos & derivados , Adolescente , Adulto , Traumatismos do Tornozelo , Avaliação de Medicamentos , Edema/tratamento farmacológico , Ácido Flufenâmico/uso terapêutico , Hematoma/tratamento farmacológico , Humanos
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa